ГОСТ ИСО 10993-7— 2016
Библиография
[1] ISO 11135-1:2007 Sterilization of health care products — Ethylene oxide — Part 1: Requirements for the
development, validation and routine control of a sterilization process for medical devices
[2]AAMI EO-VRSU 3/81; superseded byAAMI GVR-1987. Good hospital practice: Ethylene oxide gas — Ventilation
recommendations and safe use. Arlington, VA, 1981
[3]ABDEL-RAHMAN. M.S. and KADRY. A.M. Studies on the use of uncertainty factors in deriving RfDs. Hum. Есокзд.
Risk Assess.. 1. pp. 614—624. 1995
[4] ABDEL-RAHMAN. S.Z.. EL-2EIN. R.A.. AMMENHEUSE. M.M.. YANG. Z.. STOCK. T.H.. MORANDI. M. and
WARD. J.B. Jr. Variability in human sensitivity to 1,3-butadiene: Influence of the aBebc variants of the microsomal
epoxide hydrolase gene. Environ. Mol. Mutagen.. 41(2). pp. 140-6
[5] ABRAHAMS. R.H. Recent studies with workers exposed to ethylene oxide, in: Jorkasky J.F.. ed.. Safe use of
ethylene oxide. Proceedings of the Educational Seminar. Washington DC. Health Industries Manufacturers
Association. 27—38. pp. 211—220. HIMA Report No. 80-4. 1980
[6] ADAMS. C.H.. WERELY. C.J.. VICTOR. T.C.. HOAL. E.G.. ROSSOUW. G.. VAN HELDEN. P.D. Allele frequencies for
glutathione S-transferase and N-acetyltransferase 2 differ in African population groups and may be associated with
oesophageal cancer or tuberculosis incidence. Clin. Chem. Lab. Med. 41(4). pp. 600—605. 2003
[7] ADLER. N. Residual ethylene oxide and ethylene glycol in ethylene oxide sterilized pharmaceuticals. J. Pharm.
Sci. 1965: 54(5). pp. 735—742
[8]ALLEVA. F. (Cited in BALAZS[18]. 1976)
[9] ALOMAR. A.. CAMARASA. J.M. and NOGUERA. J.E.A. Ethylene oxide deimatitis. Contact Dermatitis. 7.
pp. 205—207. 1981
[10] AMBROSE. A Toxicological studies of compounds investigated for use as inhibitors of biological processes. II
Toxicity of ethylene chlorohydrin. Arch. Ind. Hyg. Occup. Med. 1950; 2:582-597.
[11]ANAND. V.P.. COGDILL. C.P.. KLAUSNER. K.A.. LISTER. L.. BARBOLT. T. PAGE. B.F.J.. URBANSKI. P. WOSS
CASIMIR. J.. BOYCE. J. Reevaluation of ethylene oxide hemolysis and irritation potential. J. Biomed. Mater. Res.
64A. pp. 648—654. 2003
[12]ANDERSEN. S. Ethylene oxide toxicity. J. Lab. Clin. Med.. 77(2). pp. 346—356. 1971
[13]AAMI ST29-1988, Recommended practice for determining residual ethylene oxide in medical devices. Association
for the Advancement of Medical Instrumentation. American National Standard. Arlington. VA. AAMI. 1988
[14] AAMI ST30-1989. Determining residual ethylene chlorohydrin and ethylene glycol in medical devices. Association
for the Advancement of Medical Instrumentation. American National Standard. Arlington. VA. AAMI. 1989
[15] ASTM E691-05. Standard practice for conducting an interlaboratory study to determine the precision of a test
method
[16] ATSDR Tp-90-16:1990. Toxicological profile for ethylene oxide. Atlanta. GA. US Department of Health and Human
Services. Public Health Service
[17]ATSDR (1997). Toxicological profile for ethylene glycol and propylene glycol. Atlanta. GA
[18]BALAZS, T. Toxicity of ethylene oxide and chloroethanol. FDA By-lines No. 3. pp. 150— 155. 1976
[19] BALL. N.A. Determination of ethylene chlorohydrin and ethylene glycol in aqueous solutions and ethylene oxide in
associated plastics. J. Pharm. Sci.. 73(9). pp. 1305— 1307. 1984
[20] BARTELS. M.J. Comparison of in vitro metabolism of ethylene glycol in rat and human liver S-9 homogenate.
Midland Ml. R&D Report of the Dow Chemical Company. 2001
[21] BASKETTER. D A . GRIFFITHS. H.A.. WANG. X.M.. WILHELM. K.P. and MCFADDEN. J. Individual, ethnic and
seasonal variability in irritant susceptibility of the skin: the implications for a predictive human patch test. Contact
Dermatitis. 35(4), pp. 208—213. 1996
[22] BELILES. R.P.. PARKER. J.C. Risk assessment and oncodynamics of ethylene oxide as related to occupational
exposure. Toxicol Ind Health 3(3). pp. 371—82, 1987
62